Abstract / truncated to 115 words (read the full abstract)

Gliomas represent about 80% of all malignant primary brain tumors. Despite recent advancements in glioma research, patient outcome remains poor. The 5 year survival rate of the most common and most malignant subtype, i.e. glioblastoma, is about 5%. Magnetic resonance imaging (MRI) has become the imaging modality of choice in the management of brain tumor patients. Conventional MRI (cMRI) provides excellent soft tissue contrast without exposing the patient to potentially harmful ionizing radiation. Over the past decade, advanced MRI modalities, such as perfusion-weighted imaging (PWI), diffusion-weighted imaging (DWI) and magnetic resonance spectroscopic imaging (MRSI) have gained interest in the clinical field, and their added value regarding brain tumor diagnosis, treatment planning and follow-up has been ... toggle 1 keyword

biomedical signal processing

Information

Author
Sauwen, Nicolas
Institution
KU Leuven
Supervisors
Publication Year
2016
Upload Date
Oct. 30, 2017

First few pages / click to enlarge

The current layout is optimized for mobile phones. Page previews, thumbnails, and full abstracts will remain hidden until the browser window grows in width.

The current layout is optimized for tablet devices. Page previews and some thumbnails will remain hidden until the browser window grows in width.